4 results match your criteria: "USA. Electronic address: skhalsa@laureateinstitute.org.[Affiliation]"
Could neurofeedback improve therapist-patient communication? Considering the potential for neuroscience informed examinations of the psychotherapeutic relationship.
Neurosci Biobehav Rev
June 2024
Laureate Institute for Brain Research, Tulsa, OK, USA; Oxley College of Health and Natural Sciences, University of Tulsa, Tulsa, OK, USA. Electronic address:
Article Synopsis
- Good communication between a patient and a therapist is really important in therapy.
- Researchers want to find ways to measure how well this communication is working by using brain scans and technology like fMRI and EEG.
- They suggest new methods that could help both patients and therapists have a better experience, but they also think about the challenges and limitations of these methods for the future.
Rhythms of the Heart, Echoes in the Brain: Exploring Interoception.
JACC Clin Electrophysiol
November 2023
Laureate Institute for Brain Research, Tulsa, Oklahoma, USA; Oxley College of Health Sciences, University of Tulsa, Tulsa, Oklahoma, USA. Electronic address:
Atrial Fibrillation as a Disorder of Heart-Brain Communication.
JACC Clin Electrophysiol
October 2022
Laureate Institute for Brain Research, Tulsa, Oklahoma, United States; VIFASOM (EA 7330 Vigilance Fatigue, Sommeil et Santé Publique), Université de Paris, Paris, France.
Impact of ibuprofen and peroxisome proliferator-activated receptor gamma on emotion-related neural activation: A randomized, placebo-controlled trial.
Brain Behav Immun
August 2021
Laureate Institute for Brain Research, 6655 S. Yale Ave., Tulsa, OK 74136 USA; School of Community Medicine, University of Tulsa, 800 S. Tucker Dr., Tulsa, OK 74104 USA. Electronic address:
Nonsteroidal anti-inflammatory drugs (NSAIDs) such as ibuprofen have shown initial promise in producing antidepressant effects. This is perhaps due to these drugs being peroxisome proliferator-activated receptor gamma (PPARγ) agonists, in addition to their inhibition of cyclooxygenase enzymes. Some, albeit mixed, evidence suggests that PPARγ agonists have antidepressant effects in humans and animals.
View Article and Find Full Text PDF